BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28062691)

  • 1. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.
    Abate F; da Silva-Almeida AC; Zairis S; Robles-Valero J; Couronne L; Khiabanian H; Quinn SA; Kim MY; Laginestra MA; Kim C; Fiore D; Bhagat G; Piris MA; Campo E; Lossos IS; Bernard OA; Inghirami G; Pileri S; Bustelo XR; Rabadan R; Ferrando AA; Palomero T
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):764-769. PubMed ID: 28062691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
    Cortes JR; Filip I; Albero R; Patiño-Galindo JA; Quinn SA; Lin WW; Laurent AP; Shih BB; Brown JA; Cooke AJ; Mackey A; Einson J; Zairis S; Rivas-Delgado A; Laginestra MA; Pileri S; Campo E; Bhagat G; Ferrando AA; Rabadan R; Palomero T
    Cell Rep; 2022 Apr; 39(3):110695. PubMed ID: 35443168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
    Morrish E; Wartewig T; Kratzert A; Rosenbaum M; Steiger K; Ruland J
    Eur J Immunol; 2023 Mar; 53(3):e2250147. PubMed ID: 36541400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
    Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
    Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.
    Robles-Valero J; Fernández-Nevado L; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Rodríguez-Fdez S; Astorga-Simón EN; Abad A; Caloto R; Bustelo XR
    EMBO J; 2021 Nov; 40(22):e108125. PubMed ID: 34617326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VAV1 mutations contribute to development of T-cell neoplasms in mice.
    Fukumoto K; Sakata-Yanagimoto M; Fujisawa M; Sakamoto T; Miyoshi H; Suehara Y; Nguyen TB; Suma S; Yanagimoto S; Shiraishi Y; Chiba K; Bouska A; Kataoka K; Ogawa S; Iqbal J; Ohshima K; Chiba S
    Blood; 2020 Dec; 136(26):3018-3032. PubMed ID: 32992343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
    Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
    J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.
    Lazer G; Pe'er L; Farago M; Machida K; Mayer BJ; Katzav S
    J Biol Chem; 2010 Jul; 285(30):23075-85. PubMed ID: 20457609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation.
    Kuhne MR; Ku G; Weiss A
    J Biol Chem; 2000 Jan; 275(3):2185-90. PubMed ID: 10636924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.
    Groysman M; Hornstein I; Alcover A; Katzav S
    J Biol Chem; 2002 Dec; 277(51):50121-30. PubMed ID: 12386169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of guanine nucleotide exchange mediated by the T-cell essential Vav1.
    Chrencik JE; Brooun A; Zhang H; Mathews II; Hura GL; Foster SA; Perry JJ; Streiff M; Ramage P; Widmer H; Bokoch GM; Tainer JA; Weckbecker G; Kuhn P
    J Mol Biol; 2008 Jul; 380(5):828-43. PubMed ID: 18589439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.
    Boddicker RL; Razidlo GL; Feldman AL
    Small GTPases; 2019 Jan; 10(1):33-39. PubMed ID: 27898263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading.
    del Pozo MA; Schwartz MA; Hu J; Kiosses WB; Altman A; Villalba M
    J Immunol; 2003 Jan; 170(1):41-7. PubMed ID: 12496381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal 20-amino acid region of guanine nucleotide exchange factor Vav1 plays a distinguished role in T cell receptor-mediated calcium signaling.
    Li SY; Du MJ; Wan YJ; Lan B; Liu YH; Yang Y; Zhang CZ; Cao Y
    J Biol Chem; 2013 Feb; 288(6):3777-85. PubMed ID: 23271736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of the nucleotide exchange activity of vav1 in T cell development and activation.
    Saveliev A; Vanes L; Ksionda O; Rapley J; Smerdon SJ; Rittinger K; Tybulewicz VL
    Sci Signal; 2009 Dec; 2(101):ra83. PubMed ID: 20009105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic alterations in new category of Peripheral T-cell lymphoma, not otherwise specified].
    Fukumoto K
    Rinsho Ketsueki; 2022; 63(12):1657-1667. PubMed ID: 36653140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model.
    Robles-Valero J; Fernández-Nevado L; Cuadrado M; Lorenzo-Martín LF; Fernández-Pisonero I; Abad A; Redín E; Montuenga L; Martín-Zanca D; Bigas A; Mallo M; Dosil M; Bustelo XR
    Mol Oncol; 2022 Oct; 16(19):3533-3553. PubMed ID: 35895495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vav1 in the lipopolysaccharide-mediated upregulation of inducible nitric oxide synthase production and nuclear factor for interleukin-6 expression activity in murine macrophages.
    Godambe SA; Knapp KM; Meals EA; English BK
    Clin Diagn Lab Immunol; 2004 May; 11(3):525-31. PubMed ID: 15138177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav1-mediated scaffolding interactions stabilize SLP-76 microclusters and contribute to antigen-dependent T cell responses.
    Sylvain NR; Nguyen K; Bunnell SC
    Sci Signal; 2011 Mar; 4(163):ra14. PubMed ID: 21386095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.